[{"data":1,"prerenderedAt":129},["ShallowReactive",2],{"s8TR8JgeojBcKHMzDgSfnc5PGO1FhDRx7PVHXyZVGdY":3,"_apollo:default":127,"_apollo:identified":128},{"allSettings":4,"seo":10,"posts":21},{"customSettings":5,"__typename":9},{"urlFront":6,"urlPreview":7,"__typename":8},"https:\u002F\u002Fblog.3ds.com","https:\u002F\u002Fblog-build-prd.itvpc.3ds.com","CustomSettings","Settings",{"social":11,"openGraph":17,"__typename":20},{"twitter":12,"__typename":16},{"cardType":13,"username":14,"__typename":15},"summary_large_image","dassault3ds","SEOSocialTwitter","SEOSocial",{"defaultImage":18,"__typename":19},null,"SEOOpenGraph","SEOConfig",{"nodes":22,"__typename":126},[23],{"id":24,"slug":25,"title":26,"uri":27,"excerpt":28,"locale":29,"featuredImage":32,"tableOfContents":40,"content":46,"date":47,"translations":48,"author":49,"tags":61,"globalTags":69,"brands":77,"industries":80,"keywords":108,"seo":116,"__typename":125},"cG9zdDozMTc0NzA=","designing-what-matters-how-indian-medtech-is-innovating-for-impact","Designing What Matters: How Indian MedTech is Innovating for Impact","\u002Findustries\u002Flife-sciences-healthcare\u002Fdesigning-what-matters-how-indian-medtech-is-innovating-for-impact","\u003Cp>Discover how India’s MedTech sector is transforming healthcare through frugal innovation and affordable technologies.\u003C\u002Fp>\n",{"locale":30,"__typename":31},"en_US","Locale",{"node":33,"__typename":39},{"large":34,"__typename":35,"medium_large":34,"thumbnail":36,"srcSet":37,"sizes":38},"https:\u002F\u002Fblog-assets.3ds.com\u002Fuploads\u002F2026\u002F10\u002Funtitled-design-10-768x432.png","MediaItem","https:\u002F\u002Fblog-assets.3ds.com\u002Fuploads\u002F2026\u002F10\u002Funtitled-design-10-150x150.png","https:\u002F\u002Fblog-assets.3ds.com\u002Fuploads\u002F2026\u002F10\u002Funtitled-design-10-300x169.png 300w, https:\u002F\u002Fblog-assets.3ds.com\u002Fuploads\u002F2026\u002F10\u002Funtitled-design-10-1024x576.png 1024w, https:\u002F\u002Fblog-assets.3ds.com\u002Fuploads\u002F2026\u002F10\u002Funtitled-design-10-768x432.png 768w, https:\u002F\u002Fblog-assets.3ds.com\u002Fuploads\u002F2026\u002F10\u002Funtitled-design-10.png 1280w","(max-width: 300px) 100vw, 300px","NodeWithFeaturedImageToMediaItemConnectionEdge",[41,42,43,44,45],"Why the 3A Model Should Define MedTech Innovation|why-the-3a-model-should-define-medtech-innovation-0","Designing for Constraint: When Limitation Becomes Competitive Advantage|designing-for-constraint-when-limitation-becomes-competitive-advantage-1","Healthcare 5.0: What Digitization Really Means for Medical Devices|healthcare-5-0-what-digitization-really-means-for-medical-devices-2","The ABC Framework: Building a Self-Sufficient MedTech Ecosystem|the-abc-framework-building-a-self-sufficient-medtech-ecosystem-3","From Volume to Value, and From Local to Global|from-volume-to-value-and-from-local-to-global-4","\n\u003Cp>What does it mean for a healthcare innovation to succeed? In India, the answer is more demanding than almost anywhere else in the world. A technology that works in a Mumbai corporate hospital but cannot function in a tier-4 city without reliable HVAC, expensive real estate, or a specialized service team has not really solved the problem. It has simply shifted it.\u003C\u002Fp>\n\n\n\n\u003Cp>This is the central argument of this episode of \u003Cem>\u003Ca href=\"https:\u002F\u002Fgo.3ds.com\u002FPODCAST-Diary6\">\u003Cstrong>3D\u003C\u002Fstrong>EXPERIENCE Innovation Matters\u003C\u002Fa>\u003C\u002Fem>, Dassault Systèmes India’s thought leadership podcast series. Ramakrishnan Venkataraman, Director SOLIDWORKS &amp; \u003Cstrong>3D\u003C\u002Fstrong>EXPERIENCE Works at Dassault Systèmes India, sits down with Gaurav Agarwal, Managing Director of Involution Healthcare, to explore what it genuinely takes to build \u003Ca href=\"https:\u002F\u002Fwww.3ds.com\u002Findustries\u002Flife-sciences-healthcare\u002Fmedical-devices?utm_campaign=202607_ind_corp_imlti_3DSInnovationMatters_en_CMP33795&amp;utm_medium=push&amp;utm_source=push4site&amp;utm_term=3DSINBLOG6\">medical \u003C\u002Fa>technology that delivers at scale across the full geographic and economic spectrum of India.\u003C\u002Fp>\n\n\n\n\u003Cblockquote class=\"is-layout-flow wp-block-quote-is-layout-flow\">\n\u003Cp>\u003Cem>\u003Cem>\u003Cem>“Innovation, in my opinion, is a medium to address clinical gaps while keeping the most important stakeholder in healthcare &#8211; the patient &#8211; at the center. If it does not improve affordability, access, and availability, it will eventually fail.”\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cem>&#8211;\u003C\u002Fem> \u003Cem>\u003Cem>\u003Cem>\u003Cem>\u003Cem>Gaurav Agarwal\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fp>\n\u003C\u002Fblockquote>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"why-the-3a-model-should-define-medtech-innovation-0\">\u003Cstrong>Why the 3A Model Should Define MedTech Innovation\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>India loses nearly three million people to cardiac disease every year. It is the country’s leading cause of death, and a significant proportion of those deaths are not the result of inadequate medicine but inadequate access. Patients in smaller cities and rural districts have historically faced journeys of 300 to 500 kilometers to reach a catheterization laboratory. The technology to treat them exists. The infrastructure to reach them does not.\u003C\u002Fp>\n\n\n\n\u003Cp>This gap between what is medicaly possible and what is operationally accessible is the problem that Gaurav believes the Indian \u003Ca href=\"https:\u002F\u002Fwww.3ds.com\u002Findustries\u002Flife-sciences-healthcare\u002Fconnected-design-in-medtech?utm_campaign=202607_ind_corp_imlti_3DSInnovationMatters_en_CMP33795&amp;utm_medium=push&amp;utm_source=push4site&amp;utm_term=3DSINBLOG6\">MedTech\u003C\u002Fa> sector must orient itself around. He frames it as the 3A model: affordability, access, and availability. These are not aspirational ideals. They are, in his view, the hard constraints that any innovation must satisfy before it can claim to have genuinely addressed a clinical need. Technologies that fail on any one of the three dimensions will not scale, regardless of how sophisticated they are in the lab.\u003C\u002Fp>\n\n\n\n\u003Cp>The implication for product design is profound. If the constraints of the end market are built into the design brief from the very beginning, and not retrofitted as cost-reduction exercises after the fact, the resulting product will be fundamentally different from one designed for the top of the market and then adapted downward. This is the design philosophy that is producing a new generation of Indian MedTech that is cheaper and more appropriate for the environments in which it must operate.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"designing-for-constraint-when-limitation-becomes-competitive-advantage-1\">\u003Cstrong>Designing for Constraint: When Limitation Becomes Competitive Advantage\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>\u003Cem>\u003Cem>\u003Cem>\u003Cem>\u003Cem>Perspective from Gaurav Agarwal, Managing Director, Involution Healthcare\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp>The conventional wisdom in capital \u003Ca href=\"https:\u002F\u002Fwww.3ds.com\u002Findustries\u002Flife-sciences-healthcare\u002Fmedical-devices?utm_campaign=202607_ind_corp_imlti_3DSInnovationMatters_en_CMP33795&amp;utm_medium=push&amp;utm_source=push4site&amp;utm_term=3DSINBLOG6\">medical\u003C\u002Fa> equipment has been that product lifecycles are long &#8211; eight, nine, ten years between major model iterations. The assumption embedded in this approach is that the market’s needs are stable enough to justify it. Gaurav challenges this directly. When the gap between what customers need and what the market offers is as wide as it is in India’s tier-3 and tier-4 cities, that pace of innovation is more neglect than caution.\u003C\u002Fp>\n\n\n\n\u003Cp>The alternative is what he calls frugal scalability: designing not for the most resourced customer, but for the most constrained one, and then letting the quality and rigor of that design carry the product upmarket. A Cath lab designed to fit in 250 square feet, require no extensive civil or HVAC infrastructure, and be maintained with indigenized components does not merely serve smaller hospitals, it challenges the assumptions that have kept cardiac care concentrated in major urban centers.\u003C\u002Fp>\n\n\n\n\u003Cp>Critically, this approach requires abandoning the idea of ‘make local for local’. Gaurav&#8217;s argument is that what is relevant in a tier-4 Indian city should, with the right design rigor, be relevant in Manhattan. Frugal innovation is not a compromise. It is a higher standard of engineering, one that must satisfy more constraints simultaneously and therefore produces solutions that are more robust.\u003C\u002Fp>\n\n\n\n\u003Cblockquote class=\"is-layout-flow wp-block-quote-is-layout-flow\">\n\u003Cp>\u003Cem>“It is no longer important to make in India for India. It is important to make local for global. What is relevant in Mumbai today should be relevant in Manhattan as well.”\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cem>&#8211; \u003Cem>\u003Cem>Ranganathan Iyer\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fp>\n\u003C\u002Fblockquote>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"healthcare-5-0-what-digitization-really-means-for-medical-devices-2\">\u003Cstrong>Healthcare 5.0: What Digitization Really Means for Medical Devices\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>\u003Cem>\u003Cem>Perspective from Ramakrishnan Venkataraman, Director, SOLIDWORKS, Dassault Systèmes India\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp>Healthcare 4.0 gave the sector electronic medical records, telemedicine, and process automation. Healthcare 5.0 is something more fundamental: collaborative AI, real-time analytics, and genuinely personalized diagnostics. The distinction matters because it changes what digitization is actually for. In the 4.0 era, digital tools were primarily administrative. In the 5.0 era, they are clinical, directly affecting diagnostic accuracy, treatment precision, and patient safety. For the \u003Ca href=\"https:\u002F\u002Fwww.3ds.com\u002Findustries\u002Flife-sciences-healthcare\u002Fconnected-design-in-medtech?utm_campaign=202607_ind_corp_imlti_3DSInnovationMatters_en_CMP33795&amp;utm_medium=push&amp;utm_source=push4site&amp;utm_term=3DSINBLOG6\">MedTech \u003C\u002Fa>companies building the devices that sit at this intersection, that shift is a product architecture question.\u003C\u002Fp>\n\n\n\n\u003Cp>The implication is direct. A \u003Ca href=\"https:\u002F\u002Fwww.3ds.com\u002Findustries\u002Flife-sciences-healthcare\u002Fmedical-devices?utm_campaign=202607_ind_corp_imlti_3DSInnovationMatters_en_CMP33795&amp;utm_medium=push&amp;utm_source=push4site&amp;utm_term=3DSINBLOG6\">medical\u003C\u002Fa> device designed to be software-upgradeable &#8211; where the hardware chassis remains stable but the prognostic, diagnostic, and therapeutic capabilities evolve over its lifetime &#8211; is a fundamentally different capital proposition from one that must be replaced wholesale when the technology moves on. The asset improves; the replacement cost does not accrue. Applied to a life-critical device like a Cath lab, this architecture also enables something more urgent: remote diagnostics that can identify system issues before they cause downtime in the cities where the device may be the only one available. That is an ethical obligation built into the design.\u003C\u002Fp>\n\n\n\n\u003Cblockquote class=\"is-layout-flow wp-block-quote-is-layout-flow\">\n\u003Cp>\u003Cem>“The real question for digitization in healthcare is whether it can keep pace with the ambition of reaching every district, every patient, at the scale India demands.”\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cem>&#8211; \u003Cem>\u003Cem>\u003Cem>\u003Cem>Ramakrishnan Venkataraman\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fp>\n\u003C\u002Fblockquote>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"the-abc-framework-building-a-self-sufficient-medtech-ecosystem-3\">\u003Cstrong>The ABC Framework: Building a Self-Sufficient MedTech Ecosystem\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>India’s \u003Ca href=\"https:\u002F\u002Fwww.3ds.com\u002Findustries\u002Flife-sciences-healthcare\u002Fconnected-design-in-medtech?utm_campaign=202607_ind_corp_imlti_3DSInnovationMatters_en_CMP33795&amp;utm_medium=push&amp;utm_source=push4site&amp;utm_term=3DSINBLOG6\">MedTech\u003C\u002Fa> sector has a structural vulnerability that its pharmaceutical sector largely overcame in the 1990s: deep import dependence on the very technologies that its own population needs most. CT scanners, MRI machines, linear accelerators, Cath labs &#8211; for decades, these were almost entirely imported, making them expensive to acquire, expensive to maintain, and vulnerable to supply chain disruption.\u003C\u002Fp>\n\n\n\n\u003Cp>Gaurav’s framework for addressing this is characteristically direct. Acknowledge the import dependencies that matter most &#8211; the ones where domestic capability would have the greatest clinical and economic impact. Build the component manufacturing infrastructure and enabling ecosystem that makes domestic production viable. And champion those efforts through public procurement, because aspiring to self-reliance while continuing to buy imported equipment is a contradiction that undermines the very ecosystem you are trying to create.\u003C\u002Fp>\n\n\n\n\u003Cp>The early results of this approach are visible. Initiatives like the Andhra Pradesh MedTech Zone, which is now among the world’s largest MedTech ecosystems, are producing CT scanners, MRIs, Cath labs and linear accelerators under one roof, many of them export-ready. India’s MedTech industry, valued at approximately $5 billion before the pandemic, is projected to reach $30 billion by 2030. The government’s Viksit Bharat framework aims to make India one of the top three global medtech markets. The trajectory is clear, what remains is the discipline to follow through.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"from-volume-to-value-and-from-local-to-global-4\">\u003Cstrong>From Volume to Value, and From Local to Global\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>The thread running through this conversation is a single, demanding idea: that the most meaningful innovations are those that close the gap between what is technically possible and what is universally accessible. India’s scale, diversity and constraints are not obstacles to building world-class MedTech. They are the conditions that make it necessary, and the proving ground that makes it credible.\u003C\u002Fp>\n\n\n\n\u003Cp>This is the shift that the sector’s most thoughtful leaders are articulating: from volume to value, from import dependence to self-sufficiency, from designing for the best-resourced customers to designing for the most constrained ones, and discovering, in the process, that the latter is the harder and more instructive engineering challenge. The \u003Ca href=\"https:\u002F\u002Fwww.3ds.com\u002F3dexperience-platform?utm_campaign=202607_ind_corp_imlti_3DSInnovationMatters_en_CMP33795&amp;utm_medium=push&amp;utm_source=push4site&amp;utm_term=3DSINBLOG6\">\u003Cstrong>3D\u003C\u002Fstrong>EXPERIENCE platform’s\u003C\u002Fa> role in enabling this &#8211; through digital continuity, simulation, and Virtual Twin technology, which allows manufacturers to validate designs against real-world constraints before committing to production &#8211; is precisely suited to this moment in India’s MedTech story.\u003C\u002Fp>\n\n\n\n\u003Cblockquote class=\"is-layout-flow wp-block-quote-is-layout-flow\">\n\u003Cp>\u003Cem>“We want to democratize cardiovascular care from India for the world. The goal is not to be a product provider, but a comprehensive solutions provider &#8211; one that proves frugal innovation and global ambition are not in tension.”\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cem>&#8211; \u003Cem>\u003Cem>\u003Cem>\u003Cem>\u003Cem>Gaurav Agarwal\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fp>\n\u003C\u002Fblockquote>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fgo.3ds.com\u002FPODCAST-Diary4\">\u003C\u002Fa>\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fdiscover.3ds.com\u002F3dexperience-innovation-matters?utm_campaign=202607_ind_corp_imlti_3DSInnovationMatters_en_CMP33795&amp;utm_medium=push&amp;utm_source=push4site&amp;utm_term=3DSINBLOG6\" data-type=\"link\" data-id=\"https:\u002F\u002Fdiscover.3ds.com\u002F3dexperience-innovation-matters?utm_campaign=202607_ind_corp_imlti_3DSInnovationMatters_en_CMP33795&amp;utm_medium=push&amp;utm_source=push4site&amp;utm_term=3DSINBLOG6\">3DEXPERIENCE Innovation Matters\u003C\u002Fa> \u003C\u002Fstrong>continues to explore the ideas and the people driving India’s most consequential industrial transformations, from the lab to the last mile.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>More Ways to Engage:\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp>🎬 Watch on \u003Ca href=\"https:\u002F\u002Fgo.3ds.com\u002FPODCAST-PAGE6\">Y\u003C\u002Fa>\u003Ca href=\"https:\u002F\u002Fgo.3ds.com\u002FPODCAST-Diary6\">ouTube\u003C\u002Fa>\u003Cbr>🎧 Listen on \u003Ca href=\"https:\u002F\u002Fopen.spotify.com\u002Fepisode\u002F7BdwlVwmnBV7EmCfkWyTSA?si=AUg6D6MITcSvvW86G9LmXg\">Spotify\u003C\u002Fa>\u003Cbr>👥 Follow us on \u003Ca href=\"https:\u002F\u002Fwww.linkedin.com\u002Fcompany\u002Fdassaultsystemes\">LinkedIn\u003C\u002Fa>\u003Cbr>📩 Get in \u003Ca href=\"https:\u002F\u002Fdiscover.3ds.com\u002F3dexperience-innovation-matters?utm_campaign=202607_ind_corp_imlti_3DSInnovationMatters_en_CMP33795&amp;utm_medium=push&amp;utm_source=push4site&amp;utm_term=3DSINBLOG6\">Touch\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Cp>\u003C\u002Fp>\n","2026-10-26T12:59:57",[],{"node":50,"__typename":60},{"nicename":51,"description":52,"slug":53,"name":54,"firstName":52,"lastName":52,"avatar":55,"__typename":59},"dassault-systemes-india","","justinaunugboji","Dassault Systemes India",{"default":56,"url":57,"__typename":58},"mm","https:\u002F\u002Fblog-assets.3ds.com\u002Fuploads\u002F2022\u002F09\u002F3ds-logo-96x96.png","Avatar","User","NodeWithAuthorToUserConnectionEdge",{"nodes":62,"__typename":68},[63],{"id":64,"name":65,"uri":66,"__typename":67},"dGVybTo4MDE0","Manufacturing","\u002Ftopics\u002Fmanufacturing\u002F","Taxonomy_topic","PostToTaxonomy_topicConnection",{"nodes":70,"__typename":76},[71],{"id":72,"name":73,"uri":74,"__typename":75},"dGVybTo4ODM0","3DEXPERIENCE platform","\u002Ftags\u002F3dexperience-platform\u002F","Taxonomy_tag","PostToTaxonomy_tagConnection",{"nodes":78,"__typename":79},[],"PostToTaxonomy_brandConnection",{"edges":81,"nodes":105,"__typename":107},[82],{"isPrimary":83,"node":84,"__typename":104},true,{"slug":85,"name":86,"industries":87,"__typename":103},"life-sciences-healthcare","Life Sciences & Healthcare",{"nodes":88,"__typename":102},[89],{"translations":90,"__typename":101},[91,95,98],{"post_title":92,"locale":93,"__typename":94},"Sciences de la vie et santé","fr_FR","Translation",{"post_title":96,"locale":97,"__typename":94},"ライフサイエンス＆ヘルスケア","ja",{"post_title":99,"locale":100,"__typename":94},"생명과학\u002F헬스케어","ko_KR","Industry","Taxonomy_industryToIndustryConnection","Taxonomy_industry","PostToTaxonomy_industryConnectionEdge",[106],{"name":86,"slug":85,"__typename":103},"PostToTaxonomy_industryConnection",{"nodes":109,"__typename":115},[110,113],{"name":111,"__typename":112},"Healthcare","Taxonomy_keyword",{"name":114,"__typename":112},"MedTech","PostToTaxonomy_keywordConnection",{"title":26,"metaDesc":117,"opengraphAuthor":52,"opengraphDescription":117,"opengraphTitle":26,"opengraphUrl":118,"opengraphSiteName":119,"opengraphPublishedTime":120,"opengraphModifiedTime":121,"twitterTitle":52,"twitterDescription":52,"readingTime":122,"metaRobotsNoindex":123,"__typename":124},"Discover how India’s MedTech sector is transforming healthcare through frugal innovation and affordable technologies.","https:\u002F\u002Fblog-frontoffice-contrib-prd.itvpc.3ds.com\u002Findustries\u002Flife-sciences-healthcare\u002Fdesigning-what-matters-how-indian-medtech-is-innovating-for-impact\u002F","Dassault Systèmes blog","2026-10-26T12:59:57+00:00","2026-10-26T13:00:00+00:00",6,"index","PostTypeSEO","Post","RootQueryToPostConnection",{},{},1793049930392]